Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Fish and Richardson
Merck
Boehringer Ingelheim
Express Scripts
Teva
Medtronic
Harvard Business School
UBS

Generated: February 19, 2018

DrugPatentWatch Database Preview

Spriaso Llc Company Profile

« Back to Dashboard

What is the competitive landscape for SPRIASO LLC, and what generic alternatives to SPRIASO LLC drugs are available?

SPRIASO LLC has one approved drug.

There are four US patents protecting SPRIASO LLC drugs.

There are fifty-six patent family members on SPRIASO LLC drugs in eleven countries.

Summary for Spriaso Llc
International Patents:56
US Patents:4
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Spriaso Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No 6,248,363 ➤ Sign Up Y ➤ Sign Up
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No 9,066,942 ➤ Sign Up ➤ Sign Up
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No 9,107,921 ➤ Sign Up Y ➤ Sign Up
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No 6,383,471 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for Spriaso Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,015,224,130 ➤ Sign Up
6,309,663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents ➤ Sign Up
6,923,988 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions ➤ Sign Up
7,374,779 Pharmaceutical formulations and systems for improved absorption and multistage release of active agents ➤ Sign Up
6,451,339 Compositions and methods for improved delivery of hydrophobic agents ➤ Sign Up
6,569,463 Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions ➤ Sign Up
6,982,281 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs ➤ Sign Up
6,761,903 Clear oil-containing pharmaceutical compositions containing a therapeutic agent ➤ Sign Up
6,458,383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin ➤ Sign Up
6,267,985 Clear oil-containing pharmaceutical compositions ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Spriaso Llc Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Harvard Business School
Cipla
Fish and Richardson
Teva
Healthtrust
Chinese Patent Office
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot